The p53 tumor suppressor network is a key responder to microenvironmental components of chronic inflammatory stress

Cancer Research

Volumn 65, Issue 22, 2005, Pages 10255-10264

  Staib, Frank ^a   Robles, Ana I ^a   Varticovski, Lyuba ^a   Wang, Xin W ^a   Zeeberg, Barry R ^a   Sirotin, Michail ^a   Zhurkin, Victor B ^a   Hofseth, Lorne J ^b   Hussain, S Perwez ^a   Weinstein, John N ^a   Galle, Peter R ^c   Harris, Curtis C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; NITRIC OXIDE; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BIOINFORMATICS; CANCER CELL; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CHRONIC INFLAMMATION; COLON CANCER; CONTROLLED STUDY; DNA MICROARRAY; DNA REPLICATION; FLOW CYTOMETRY; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE TARGETING; HUMAN; HUMAN CELL; HYPOXIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION;

CELL CYCLE; CELL HYPOXIA; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HCT116 CELLS; HUMANS; HYDROGEN PEROXIDE; INFLAMMATION; NITRIC OXIDE DONORS; NITROGEN OXIDES; OXIDATIVE STRESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPERMINE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 28544431948     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-1714     Document Type: Article

References (51)

1. Hofseth LJ, Hussain SP, Harris CC. p53: 25 years after its discovery. Trends Pharmacol Sci 2004;25:177-81.
2. Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer 2003;3:276-85.
3. Li CQ, Robles AI, Hanigan CL, et al. Apoptotic signaling pathways induced by nitric oxide in human lymphoblastoid cells expressing wild-type or mutant p53. Cancer Res 2004;64:3022-9.
4. Hofseth LJ, Saito S, Hussain SP, et al. Nitric oxide-induced cellular stress and p53 activation in chronic inflammation. Proc Natl Acad Sci U S A 2003;100:143-8.
5. Hussain SP, Amstad P, Raja K, et al. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. Cancer Res 2000;60:3333-7.
6. Hussain SP, Raja K, Amstad PA, et al. Increased p53 mutation load in nontumorous human liver of Wilson disease and hemochromatosis: oxyradical overload diseases. Proc Natl Acad Sci U S A 2000;97:12770-5.
7. Hofseth LJ, Hussain SP, Wogan GN, Harris CC. Nitric oxide in cancer and chemoprevention. Free Radic Biol Med 2003;34:955-68.
8. Ames BN, Gold LS, Willett WC. The causes and prevention of cancer. Proc Natl Acad Sci U S A 1995;92:5258-65.
9. Robles AI, Harris CC. p53-mediated apoptosis and genomic instability diseases. Acta Oncol 2001;40:696-701.
10. Sancar A, Lindsey-Boltz LA, Unsal-Kaccmaz K, Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 2004;73:39-85.
11. Hammond EM, Green SL, Giaccia AJ. Comparison of hypoxia-induced replication arrest with hydroxyurea and aphidicolin-induced arrest. Mutat Res 2003;532:205-13.
12. Lewis JS, Lee JA, Underwood JC, Harris AL, Lewis CE. Macrophage responses to hypoxia: relevance to disease mechanisms. J Leukoc Biol 1999;6:889-900.
13. Hammond EM, Denko NC, Done MJ, Abraham RT, Giaccia AJ. Hypoxia links ATR and p53 through replication arrest. Mol Cell Biol 2002;2:1834-43.
14. Zhou J, Schmid T, Brune B. HIF-1α and p53 as targets of NO in affecting cell proliferation, death and adaptation. Curr Mol Med 2004;4:741-51.
15. Zolzer F, Stuben G, Knuhmann K, Streffer C, Sack H. Quiescent S-phase cells as indicators of extreme physiological conditions in human tumor xenografts. Int J Radiat Oncol Biol Phys 1999;45:1019-24.
16. Lawrence T, Bebien M, Liu GY, Nizet V, Karin M. IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation. Nature 2005;434:1138-43.
17. Imhof A, Heinzer I. Continuous monitoring of oxygen concentrations in several systems for cultivation of anaerobic bacteria. J Clin Microbiol 1996;34:1646-8.
18. Zeeberg BR, Qin H, Narasimhan S, et al. High-Throughput GoMiner, an "industrial-strength" integrative Gene Ontology tool for interpretation of multiple-microarray experiments, with application to studies of Common Variable Immune Deficiency (CVID). BMC Bioinformatics 2005;6:168.
19. Bard J. Ontologies: formalising biological knowledge for bioinformatics. Bioessays 2003;25:501-6.
20. Stormo GD, Hartzell GW III. Identifying protein-binding sites from unaligned DNA fragments. Proc Natl Acad Sci U S A 1989;86:1183-7.
21. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7.
22. Hofseth LJ, Khan MA, Ambrose M, et al. The adaptive imbalance in base excision-repair enzymes generates microsatellite instability in chronic inflammation. J Clin Invest 2003;12:1887-94.
23. Weigel AL, Handa JT, Hjelmeland LM. Microarray analysis of H2O2-, HNE-, or tBH-treated ARPE-19 cells. Free Radic Biol Med 2002;3:1419-32.
24. Chuang YY, Chen Y, Gadisetti, et al. Gene expression after treatment with hydrogen peroxide, menadione, or t-butyl hydroperoxide in breast cancer cells. Cancer Res 2002;62:6246-54.
25. Denko NC, Fontana LA, Hudson KM, et al. Investigating hypoxic tumor physiology through gene expression patterns. Oncogene 2003;2:5907-14.
26. Robinson M, Jiang P, Cui J, et al. Global genechip profiling to identify genes responsive to p53-induced growth arrest and apoptosis in human lung carcinoma cells. Cancer Biol Ther 2003;2:406-15.
27. Mirza A, Wu Q, Wang L, et al. Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression. Oncogene 2003;2:3645-54.
28. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000;408:307-10.
29. Zhao R, Gish K, Murphy M, et al. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev 2000;14:981-93.
30. Wang L, Wu Q, Qiu P, et al. Analyses of p53 target genes in the human genome by bioinformatic and microarray approaches. J Biol Chem 2001;276:43604-10.
31. Ho J, Benchimol S. Transcriptional repression mediated by the p53 tumour suppressor. Cell Death Differ 2003;10:404-8.
32. Sengupta S, Shimamoto A, Koshiji M, et al. Tumor suppressor p53 represses transcription of RECQ4 helicase. Oncogene 2005;24:1738-48.
33. Forrester K, Ambs S, Lupold SE, et al. Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase (NOS2) expression by wild-type p53. Proc Natl Acad Sci U S A 1996;93:2442-7.
34. Matsui T, Katsuno Y, Inoue T, et al. Negative regulation of Chk2 expression by p53 is dependent on the CCAAT-binding transcription factor NF-Y. J Biol Chem 2004;279:25093-100.
35. Park IK, Qian D, Kiel M, et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 2003;423:302-5.
36. Kim JH, Yoon SY, Kim CN, et al. The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins. Cancer Lett 2004;203:217-24.
37. Brune B, Zhou J. The role of nitric oxide (NO) in stability regulation of hypoxia inducible factor-1α (HIF-1α). Curr Med Chem 2003;10:845-55.
38. Kasuno K, Takabuchi S, Fukuda K, et al. Nitric oxide induces hypoxia-inducible factor 1 activation that is dependent on MAPK and phosphatidylinositol 3-kinase signaling. J Biol Chem 2004;279:2550-8.
39. Thomas DD, Espey MG, Ridnour LA, et al. Hypoxic inducible factor 1α, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide. Proc Natl Acad Sci U S A 2004;101:894-9.
40. Zhou J, Brune B. NO and transcriptional regulation: from signaling to death. Toxicology 2005;208:223-33.
41. Jung F, Palmer LA, Zhou N, Johns RA. Hypoxic regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes. Circ Res 2000;86:319-25.
42. Park SY, Lee H, Hur J, et al. Hypoxia induces nitric oxide production in mouse microglia via p38 mitogen-activated protein kinase pathway. Brain Res Mol Brain Res 2002;107:9-16.
43. Palmer LA, Semenza GL, Stoler MH, Johns RA. Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1. Am J Physiol 1998;274:L212-9.
44. Melillo G, Musso T, Sica A, Taylor LS, Cox GW, Varesio L. A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J Exp Med 1995;182:1683-93.
45. Chun YS, Kim MS, Park JW. Oxygen-dependent and - independent regulation of HIF-1α. J Korean Med Sci 2002;17:581-8.
46. Ambs S, Ogunfusika MO, Merriam WG, Bennett WP, Billiar TR, Harris CC. Upregulation of NOS2 expression in cancer-prone p53 knockout mice. Proc Natl Acad Sci U S A 1998;95:8823-8.
47. DeSesso JM. Cell death and free radicals: a mechanism for hydroxyurea teratogenesis. Med Hypotheses 1979;5:937-51.
48. Sakano K, Oikawa S, Hasegawa K, Kawanishi S. Hydroxyurea induces site-specific DNA damage via formation of hydrogen peroxide and nitric oxide. Jpn J Cancer Res 2001;92:1166-74.
49. Fontecave M. Ribonucleotide reductases and radical reactions. Cell Mol Life Sci 1998;54:684-95.
50. Roy B, Guittet O, Beuneu C, Lemaire G, Lepoivre M. Depletion of deoxyribonucleoside triphosphate pools in tumor cells by nitric oxide. Free Radic Biol Med 2004;36:507-16.
51. Green SL, Giaccia AJ. Tumor hypoxia and the cell cycle: implications for malignant progression and response to therapy. Cancer J Sci Am 1998;4:218-23.